Results 11 to 20 of about 387,869 (336)

Hepatitis B vaccine in infants: a randomized controlled trial comparing gluteal versus anterolateral thigh muscle administration [PDF]

Revista do Instituto de Medicina Tropical de São Paulo, 2001
A significantly diminished antibody response to hepatitis B vaccine has been demonstrated in adults when the buttock is used as the injection site.
Andrea Santos Rafael ALVES, Cristiane M.R. NASCIMENTO, Celso H. GRANATO, Helena Keiko SATO, Marina F. MORGATO, Claudio S. PANNUTI   +5 more
doaj   +2 more sources

Long-term hepatitis B vaccine immunity in Ethiopian children that received a pentavalent vaccine series: a retrospective cohort study [PDF]

International Journal of Infectious Diseases
Introduction: Chronic hepatitis B affects close to 300 million people globally with 1.5 million new infections per year. It causes the highest numbers of cirrhosis and liver cancer diagnoses each year. In children, perinatal transmission and contact with
Dr Tinsae Alemayehu, Dr Million Dechassa Daba, Dr Danilo Buonsenso   +2 more
doaj   +2 more sources

A controlled clinical trial of the efficacy of the hepatitis B vaccine (heptavax B): A final report [PDF]

Hepatology, 1981
W. Szmuness, C. Stevens, E. Zang, E. Harley, A. Kellner   +4 more
semanticscholar   +2 more sources

Action Mechanisms and Scientific Rationale of Using Nasal Vaccine (HeberNasvac) for the Treatment of Chronic Hepatitis B

Vaccines, 2022
Nasvac (HeberNasvac®) is a novel therapeutic vaccine for chronic hepatitis B (CHB). This product is a formulation of the core (HBcAg) and surface (HBsAg) antigens of the hepatitis B virus (HBV), administered by nasal and subcutaneous routes, in a ...
Julio Cesar Aguilar, Jorge Agustin Aguiar, Sheikh Mohammad Fazle Akbar   +2 more
doaj   +1 more source

Protection and antibody levels 35 years after primary series with hepatitis B vaccine and response to a booster dose

Hepatology, 2022
The duration of protection from hepatitis B vaccination in children and adults is not known. In 1981, we used three doses of plasma‐derived hepatitis B vaccine to immunize a cohort of 1578 Alaska Native adults and children from 15 Alaska communities who ...
M. Bruce, Dana Bruden, D. Hurlburt, J. Morris, Sara S. Bressler, G. Thompson, Danielle Lecy, K. Rudolph, L. Bulkow, T. Hennessy, Brenna C. Simons, Mark K. Weng, Noele P. Nelson, B. McMahon   +13 more
semanticscholar   +1 more source

Knowledge and associated factors for the uptake of hepatitis B vaccine among nonmedical undergraduate students in a private university in Ekiti State, Nigeria

Nigerian Journal of Medicine, 2022
Background: Hepatitis B is a life-threatening viral infection that causes acute and chronic diseases of the liver. Hepatitis B infection is endemic in Nigeria with a national pooled prevalence rate of 9.5%.
Olusegun Elijah Elegbede, Ayodele Kamal Alabi, Taiye Adeyanju Alao, Taofeek Adedayo Sanni   +3 more
doaj   +1 more source

Immunogenicity and Safety of a 3-Antigen Hepatitis B Vaccine vs a Single-Antigen Hepatitis B Vaccine

JAMA Network Open, 2021
Key Points Question What is the immunogenicity and safety of a 3-antigen hepatitis B virus (HBV) vs a single-antigen HBV vaccine among young adults? Findings This randomized clinical trial of 2838 participants found that the 3-antigen HBV vaccine was ...
T. Vesikari, A. Finn, P. van Damme, I. Leroux-Roels, G. Leroux-Roels, N. Segall, Azhar Toma, G. Vallieres, R. Aronson, D. Reich, S. Arora, P. Ruane, Clancy L Cone, M. Manns, C. Cosgrove, S. Faust, M. Ramasamy, Nathalie Machluf, J. Spaans, B. Yassin-Rajkumar, D. Anderson, V. Popovic, F. Diaz-Mitoma   +22 more
semanticscholar   +1 more source

Inspiration to mRNA-based COVID-19 vaccination: Serious adverse case reports with hepatitis B vaccine in real-world

Frontiers in Pediatrics, 2022
ObjectivesThe hepatitis B vaccine comprises hepatitis B surface antigen (HBsAg) produced by transgenic yeast cells. There are few serious adverse events (SAE) reports after Hepatitis B vaccination.MethodsThe authors searched the Chinese legal documents ...
Jinmiao Lu, Xunjie Zhang, Hong Xu, Zhiping Li   +3 more
doaj   +1 more source

Hepatitis B Vaccines [PDF]

The Journal of Infectious Diseases, 2017
Abstract Hepatitis B is caused by the hepatitis B virus (HBV), which infects the liver and may lead to chronic liver disease, including cirrhosis and hepatocellular carcinoma. HBV represents a worldwide public health problem, causing major morbidity and mortality.
Pattyn, Jade, Hendrickx, Greet, Vorsters, Alex, van Damme, Pierre   +3 more
openaire   +4 more sources

Effect of a Community-Based Hepatitis B Virus Infection Detection Combined with Vaccination Program in China

Vaccines, 2021
Evidence on the effectiveness of hepatitis B virus (HBV) infection screening and vaccination programs remains rare in China. We used a quasi-experimental method, propensity score matching, to evaluate the effects of a community-based HBV infection ...
Xinyao Liu, Wuqi Qiu, Yan Liang, Wei Zhang, Qian Qiu, Xinxin Bai, Guolin Dai, Hao Ma, Hongpu Hu, Wei Zhao, Guangyu Hu   +10 more
doaj   +1 more source